-
Mashup Score: 8Now That We Don't Talk: Should Cancer Centers Bill for Patient Portal Messages in Oncology? - 1 month(s) ago
Published online: March 21, 2024 Request permissions for this article. Massachusetts General Hospital, Concord, MA Now That We Don’t Talk: Should Cancer Centers Bill for Patient Portal Messages in Oncology?. JCO Oncol Pract 0, OP.24.00176 DOI: 10.1200/OP.24.00176 If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download. For more information or tips please see
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
PURPOSE Although patients with metastatic breast cancer (MBC) have been living longer with the advent of more effective treatments such as targeted therapy and immunotherapy, the disease remains incurable, and most patients will undergo therapy indefinitely. When beginning therapy, patients are typically prescribed dose often based upon the maximum tolerated dose identified in phase I clinical trials. However, patients’ perspectives about tolerability and willingness to discuss individualized dosing of drugs upon initiation of a new regimen and throughout the course of treatment have not been comprehensively evaluated. METHODS Patient advocates and medical oncologists from the Patient-Centered Dosing Initiative (PCDI) developed a survey to ascertain the prevalence and severity of MBC patients’ treatment-related side effects, the level of patient-physician communication, mitigation strategies, perception about the relative efficacy of higher versus lower doses, and willingness to discus
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 23Vaccination of Adults With Cancer: ASCO Guideline Clinical Insights - 2 month(s) ago
This clinical insights article is derived from recommendations in Vaccination of Adults with Cance r: ASCO Guideline. This document is based on an ASCO Guideline and is not intended to substitute for the independent professional judgment of the treating physician. Practice guidelines do not account for individual variation among patients. This clinical insights article does not purport to suggest any particular course of medical treatment. Use of the guideline and this clinical insights article are
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline Q&A - 2 month(s) ago
@JCO_ASCO guideline on #cannabis in cancer with @JCOOP_ASCO companion Q&A addressing key clinical questions
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Virtual Follow-Up in Patients Initiating Antineoplastic Treatment in the Ambulatory Setting - 2 month(s) ago
PURPOSE Initiating antineoplastic therapy can be distressful and affect patient retention of treatment-related side effects and safety protocols. Return visits can range from 8 to 28 days after treatment, during which patients may develop treatment-related questions and toxicities. This study’s objective is to evaluate how implementing a follow-up phone call 24-48 hours after initial antineoplastic infusion, compared with standard pretreatment education, affects patient satisfaction and education retention. METHODS We conducted a single-center pilot study where patients who were literate, English-speaking, with genitourinary malignancies, initiating intravenous chemotherapy or immunotherapy were eligible. The primary end point was patient knowledge retention. Secondary end points included patient satisfaction. The Leuven’s Questionnaire Patient Knowledge Tool, a validated, standardized tool, was used to evaluate patient knowledge retention, with a higher score indicating more retention
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet-
This small (n=31) pilot finds proactive #telehealth telephone f/u for GU oncology pts improves education retention & satisfaction. Pts were more likely to retain info about potential side effects, triaging resources, & supportive therapy. ➡️ https://t.co/3xUTzyzDYz @DrRanaMcKay https://t.co/q83Bn0GZ0o
-
-
Mashup Score: 4Demographic and Clinical Factors Associated With Health-Related Quality-of-Life Profiles Among Prostate Cancer Survivors - 2 month(s) ago
PURPOSE Our purpose was to describe the prevalence and predictors of symptom and function clusters related to physical, emotional, and social components of general health-related quality of life (HRQOL) in a population-based sample of prostate cancer (PCa) survivors. METHODS Participants (N = 1,162) completed a baseline survey at a median of 9 months after diagnosis to ascertain the co-occurrence of eight symptom and functional domains that are common across all cancers and not treatment-specific. We used latent profile analysis (LPA) to identify subgroup profiles of survivors with low, moderate, or high HRQOL levels. Multinomial logistic regression models were used to identify clinical and sociodemographic factors associated with survivors’ membership in the low versus moderate or high HRQOL profile. RESULTS The LPA identified 16% of survivors who were categorized in the low HRQOL profile at baseline, indicative of the highest symptom burden and lowest functioning. Factors related to
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet-
16% #prostatecancer survivors experienced elevated physical & psychosocial symptoms that were independent of local curative therapy. Younger age, race, comorbidity, & lower financial/spiritual well-being were risk factors for poor #HRQOL: https://t.co/fBmCadnz2j @ReeveBryce #pcsm https://t.co/fBqjkmJqLI
-
-
Mashup Score: 8
PURPOSE The symptoms with which a patient with cancer presents and the route taken to diagnosis (emergency v nonemergency) may affect the speed with which the diagnosis of cancer is made, thereby affecting outcomes. We examined time to diagnosis by symptom for cancers diagnosed through emergency and nonemergency routes (NERs). METHODS We performed a retrospective review of patients diagnosed with 10 solid cancers at Hospital Clínic of Barcelona between March 2013 and June 2023. Cancers were diagnosed through emergency presentation and admission (inpatient emergency route [IER]), emergency presentation and outpatient referral (outpatient emergency route [OER]), and primary care presentation and outpatient referral (NER). We assessed the effect of diagnostic routes on intervals to diagnosis for 19 cancer symptoms. RESULTS A total of 5,174 and 1,607 patients were diagnosed with cancer through emergency routes and NERs, respectively. Over 85% of patients presenting with alarm (localizing)
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet-
Time to new cancer diagnosis varies by symptom & medical path to dx (ER/in patient or non-emergency). For pts with "alarm" (local) symptoms, time to dx was shorter than for those with non-localizing sx like weight loss. ⏱️ was shorter w/ ER evaluation. ➡️ https://t.co/yNDKRTWCCZ https://t.co/X43tNxAazV
-
-
Mashup Score: 2Perceived Barriers Toward Patient-Reported Outcome Implementation in Cancer Care: An International Scoping Survey - 2 month(s) ago
PURPOSE Implementation of patient-reported outcomes (PROs) collection is an important priority in cancer care. We examined perceived barriers toward implementing PRO collection between centers with and without PRO infrastructure and administrators and nonadministrators. PATIENTS AND METHODS We performed a multinational survey of oncology practitioners on their perceived barriers to PRO implementations. Multivariable regression models evaluated for differences in perceived barriers to PRO implementation between groups, adjusted for demographic and institutional variables. RESULTS Among 358 oncology practitioners representing six geographic regions, 31% worked at centers that did not have PRO infrastructure and 26% self-reported as administrators. Administrators were more likely to perceive concerns with liability issues (aOR, 2.00 [95% CI, 1.12 to 3.57]; P = .02) while having nonsignificant trend toward less likely perceiving concerns with disruption of workflow (aOR, 0.58 [95% CI, 0.32
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Health Care Contact Days Among Older Cancer Survivors - 2 month(s) ago
PURPOSE Health care contact days—days spent receiving health care outside the home—represent an intuitive, practical, and person-centered measure of time consumed by health care. METHODS We linked 2019 Medicare Current Beneficiary Survey and traditional Medicare claims data for community-dwelling older adults with a history of cancer. We identified contact days (ie, spent in a hospital, emergency department, skilled nursing facility, or inpatient hospice or receiving ambulatory care including an office visit, procedure, treatment, imaging, or test) and described patterns of total and ambulatory contact days. Using weighted Poisson regression models, we identified factors associated with contact days. RESULTS We included 1,168 older adults representing 4.51 million cancer survivors (median age, 76.4 years, 52.8% women). The median (IQR) time from cancer diagnosis was 65 (27-126) months. In 2019, these adults had mean (standard deviation) total contact days of 28.4 (27.6) and ambulatory
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet-
In this nationally representative study, community-dwelling, older #CancerSurvivors spent on avg. 28 days over a year receiving health care outside their homes. There are missed opportunities to coordinate care & reduce #TimeToxicity. ➡️ https://t.co/pXnb4cQhTx #SurvOnc #gerionc https://t.co/nV2sbQ9SzK
-
-
Mashup Score: 7Mixed-Methods Study on the Responsiveness of the Comprehensive Score for Financial Toxicity Among People With Multiple Myeloma - 2 month(s) ago
PURPOSE Financial toxicity is a contributor to the psychosocial burden of cancer care. There is no consensus measure of financial toxicity; however, recent studies have adopted the Comprehensive Score for Financial Toxicity (COST). Despite its growing popularity, data on the responsiveness to change of the COST instrument are lacking. To address this gap in the literature, we performed a sequential mixed-methods study of people with multiple myeloma. MATERIALS AND METHODS In the quantitative phase of the study, we collected COST scores at two time points approximately 8 weeks apart from 72 patients. In the qualitative phase, we conducted semistructured interviews with a subset of 12 patients who reported the largest changes in scores. The qualitative data were analyzed using a deductive coding scheme developed using the Framework Method in the context of a commonly cited conceptual model of financial toxicity. RESULTS The median absolute change in COST scores was four points (IQR, 2-6)
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet-
From "very fortunate" to “robbing Peter to pay Paul,” this mixed methods study of pts w/ #MultipleMyeloma finds 50% had ⬇️ COST score over time, however only 25% on qualitative interviews felt they were experiencing #financialToxicity. ➡️ https://t.co/ObjSyjzuaB @ravivij #mmsm https://t.co/vp2Pil99XA
-
#JCOOP Editorial: "Should Cancer Centers Bill for Patient Portal Messages in Oncology?" ⌨️ On optimizing portal message management & promoting further research on best practices, potential disparities & the impact of billing by @EthicsdoctorP. ➡️ https://t.co/sP9p0fN4Fq https://t.co/qHvHEkn2QO